State Street
HCAT icon

State Street’s Health Catalyst HCAT Stock Holding History

State Street’s Portfolio HCAT Stock Details HCAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$718K Sell
360,713
-964,136
-73% -$1.39M ﹤0.01% 3510
2026
Q1 		$1.68M Sell
1,324,849
-3,073
-0.2% -$5.78K ﹤0.01% 3346
2025
Q4 		$3.17M Buy
1,327,922
+54,168
+4% +$148K ﹤0.01% 3183
2025
Q3 		$3.63M Buy
1,273,754
+46,880
+4% +$160K ﹤0.01% 3121
2025
Q2 		$4.63M Buy
1,226,874
+40,722
+3% +$160K ﹤0.01% 2980
2025
Q1 		$5.37M Sell
1,186,152
-26,237
-2% -$139K ﹤0.01% 2850
2024
Q4 		$8.57M Buy
1,212,389
+48,635
+4% +$387K ﹤0.01% 2714
2024
Q3 		$9.47M Buy
1,163,754
+28,251
+2% +$204K ﹤0.01% 2641
2024
Q2 		$7.26M Sell
1,135,503
-187,223
-14% -$1.2M ﹤0.01% 2748
2024
Q1 		$9.96M Buy
1,322,726
+35,194
+3% +$321K ﹤0.01% 2588
2023
Q4 		$11.9M Sell
1,287,532
-172,973
-12% -$1.41M ﹤0.01% 2495
2023
Q3 		$14.8M Buy
1,460,505
+41,742
+3% +$498K ﹤0.01% 2357
2023
Q2 		$17.7M Buy
1,418,763
+22,860
+2% +$272K ﹤0.01% 2318
2023
Q1 		$16.3M Buy
1,395,903
+45,143
+3% +$575K ﹤0.01% 2366
2022
Q4 		$14.4M Buy
1,350,760
+214,486
+19% +$2.07M ﹤0.01% 2470
2022
Q3 		$11M Buy
1,136,274
+11,928
+1% +$158K ﹤0.01% 2650
2022
Q2 		$16.3M Buy
1,124,346
+107,699
+11% +$1.84M ﹤0.01% 2395
2022
Q1 		$26.6M Buy
1,016,647
+57,355
+6% +$1.63M ﹤0.01% 2187
2021
Q4 		$38M Buy
959,292
+41,865
+5% +$1.91M ﹤0.01% 2002
2021
Q3 		$45.9M Buy
917,427
+74,546
+9% +$4.07M ﹤0.01% 1870
2021
Q2 		$46.8M Buy
842,881
+167,804
+25% +$8.94M ﹤0.01% 1893
2021
Q1 		$31.6M Sell
675,077
-24,731
-4% -$1.2M ﹤0.01% 2067
2020
Q4 		$30.5M Buy
699,808
+69,034
+11% +$2.55M ﹤0.01% 1969
2020
Q3 		$23.1M Buy
630,774
+44,714
+8% +$1.52M ﹤0.01% 1948
2020
Q2 		$17.1M Buy
586,060
+242,799
+71% +$6.71M ﹤0.01% 2120
2020
Q1 		$8.98M Buy
343,261
+164,831
+92% +$5.04M ﹤0.01% 2342
2019
Q4 		$6.19M Buy
178,430
+48,245
+37% +$1.6M ﹤0.01% 2751
2019
Q3 		$4.12M Buy
+130,185
New +$5.12M ﹤0.01% 2878

Other funds holding HCAT

FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
CF
CDC Financial Chicago, Illinois $239M AUM
PVM
Palogic Value Management Dallas, Texas $304M AUM 15.15% 1-Year Est. Return
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $15.4B AUM 26.43% 1-Year Est. Return
NI
Nepsis Inc Minneapolis, Minnesota $295M AUM 35.44% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street's HCAT Position: Q2 2026 in Review

State Street reduced its Health Catalyst (HCAT) stake by 73% in Q2 2026, selling an estimated $1.39M and leaving 360,713 shares worth $718K. The position accounts for ﹤0.01% of the portfolio, ranked #3510.

State Street first reported a position in HCAT in Q3 2019 and has held it in 28 quarters since. The position peaked at $46.8M in Q2 2021. 127 funds tracked by Wall St. Rank hold HCAT as of Q2 2026.

  • State Street held 360,713 shares of Health Catalyst worth $718K as of Q2 2026.
  • State Street sold 964,136 Health Catalyst shares in Q2 2026, an estimated $1.39M.
  • Health Catalyst made up ﹤0.01% of State Street's portfolio in Q2 2026, its #3510 holding.
  • State Street first reported a position in Health Catalyst in Q3 2019 and has held it in 28 quarters since.
  • State Street's Health Catalyst position peaked at $46.8M in Q2 2021.
  • 127 funds tracked by Wall St. Rank held Health Catalyst as of Q2 2026.

Based on State Street's 13F filing for Q2 2026, filed 7 Aug 2026.